Although these functions are often managed separately within organizations, in practice they depend heavily on each other. Clinical operations cannot move forward without a reliable and timely supply of materials and investigational products. At the same time, clinical supply planning cannot be effective without clear operational timelines, site needs, and study execution details.
In short, both functions are essential for success, and neither can perform well in isolation. Starting from the 2027 editions of the Clinical Trials Conclave organized by World BI, we will continue to bring these two critical areas together by focusing on both clinical trial supply + clinical operations within the Clinical Trial Supply Forum.
Understanding the Two Functions
Clinical Operations
The Execution Backbone
Clinical operations is responsible for the day-to-day execution of a clinical trial. It ensures that studies are run smoothly across all participating sites and countries.
Key responsibilities include:
- Selecting and activating study sites
- Recruiting and retaining patients
- Monitoring sites and managing study conduct
- Ensuring adherence to the study protocol
- Overseeing data collection and overall trial execution
Clinical Trial Supply
The Delivery Engine
Clinical trial supply (CTS) is responsible for making sure that the right treatment reaches the right patient at the right time during a study. It acts as the delivery backbone that supports the entire clinical trial process.
Its key responsibilities include:
- Manufacturing and packaging of the investigational product (IP)
- Designing randomization and overall supply strategy for the trial
- Distributing supplies to clinical sites around the world
- Managing temperature-controlled and sensitive logistics
- Forecasting demand and planning future supply needs
- Handling returns, reconciliation, and final destruction of materials
Where the Two Intersect
Clinical operations and clinical trial supply are closely linked and interact at almost every key stage of a clinical trial. Their alignment is essential for keeping studies on track, on time, and within budget.
Study Design & Feasibility
- Clinical operations defines the patient population and site strategy
- Clinical supply uses these assumptions to forecast demand and plan inventory
When both functions are not aligned early, it can lead to either excess supply or shortages during the trial.
Site Activation
- Clinical operations is responsible for activating sites and starting recruitment
- Clinical supply ensures investigational product (IP) is available according to activation timelines
If supply is delayed, site initiation can be significantly slowed or even put on hold.
Patient Recruitment & Randomization
- Clinical operations manages patient enrollment and screening activities
- Clinical supply supports treatment allocation and randomization across study arms
The speed of recruitment directly influences how quickly clinical supplies are used and replenished.
Global Logistics & Site Support
- Clinical operations oversees site conduct, performance, and compliance
- Clinical supply manages global distribution and maintains temperature-controlled logistics
Any disruption in the supply chain can quickly affect site performance and trial continuity.
Amendments & Mid-Trial Changes
- Changes in protocol driven by clinical operations often impact supply requirements
- Clinical supply must quickly adjust forecasting, packaging, and labeling to match new needs
Poor coordination during these changes can result in delays that may extend the trial timeline by months.
Why This Relationship Matters More Than Ever
Modern clinical trials are becoming increasingly complex and dynamic. New approaches such as decentralized models, adaptive designs, and global multi-region studies are changing how trials are planned and executed. At the same time, personalized medicine and smaller patient populations are making supply and operations even more sensitive and interdependent. Increased regulatory expectations add further pressure on timelines and execution quality. In this environment, there is very little room for error.
When clinical operations and clinical trial supply are not properly aligned, the impact is quickly visible across the study, including:
Misalignment Consequences
- Delays in patient recruitment and trial timelines
- Overproduction of drug supply or critical shortages at sites
- Higher operational costs due to inefficiencies
- Frustration and reduced engagement at clinical sites
- Increased regulatory and compliance risks
As trials evolve in complexity, the collaboration between clinical operations and clinical supply is no longer optional. It is essential for ensuring successful and efficient study execution.
The Shift Toward Integration
Leading pharmaceutical and biotech companies are increasingly moving away from siloed ways of working and toward more integrated models where clinical operations and clinical trial supply function as one connected system. This shift is being driven by the growing complexity of modern clinical trials and the need for faster, more reliable execution.
Integrated Planning Models
Organizations are now adopting joint planning approaches where clinical operations and supply teams collaborate on forecasting, study timelines, and demand planning from the very beginning.
Cross-Functional Trial Teams
Instead of working in isolation, supply chain experts are increasingly embedded within clinical operations teams to improve coordination, decision-making, and responsiveness during trial execution.
Data-Driven Forecasting
Real-time enrollment and site activity data are being used to continuously adjust supply forecasts, helping ensure that drug availability closely matches actual trial demand.
Digital Clinical Supply Chains
Advanced technologies, including AI-driven demand prediction and automated resupply systems, are transforming how clinical supplies are planned, managed, and distributed.
The Future: One Ecosystem, Not Two Functions
The future of clinical trials is no longer about treating clinical operations and clinical trial supply as separate functions. Instead, it is moving toward a fully connected clinical execution ecosystem.
In this model, both functions work as one integrated system, continuously sharing data, decisions, and timelines. At World BI’s Clinical Trial Supply Forum, this shift is increasingly reflected in how industry leaders are shaping discussions around end-to-end trial execution and collaboration.
- Recruitment data is used in real time to guide and adjust clinical trial supply decisions
- Supply constraints are considered early in study design and feasibility planning
- Clinical operations and clinical trial supply collaborate closely from protocol development through to study close-out
At World BI's Clinical Trial Supply Forum, this shift is increasingly reflected in how industry leaders are shaping discussions around end-to-end trial execution and collaboration.
Explore the CTS ForumThis shift represents a fundamental change in how clinical trials are run moving from functional silos to a unified, data-driven execution model that improves speed, efficiency, and overall trial success.